Warby Parker (WRBY) Non-Current Assets (2020 - 2026)
Warby Parker's (WRBY) quarterly Non-Current Assets came in at $378.7 million in Q1 2026, up 7.54% YoY from $352.2 million in Q1 2025, and up 2.78% on a QoQ basis from $368.5 million in Q4 2025.
Warby Parker (WRBY) Non-Current Assets (2020 - 2026) Analysis & Trends
Warby Parker (WRBY) has 7 years of Non-Current Assets data on file, last reported at $378.7 million in Q1 2026.
- Quarterly Non-Current Assets rose 7.54% year-over-year to $378.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 10.3% YoY) and the FY2025 annual result came in at $368.5 million, up 5.15% from the prior year.
- Non-Current Assets improved to $378.7 million in Q1 2026, from $368.5 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $378.7 million in Q1 2026 to a low of $232.5 million in Q1 2022.
- A 5-year average of $307.2 million and a median of $296.8 million in 2024 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets jumped 152.61% — and 2023, when it climbed 2.76%.
- Tracing WRBY's Non-Current Assets over 5 years: stood at $274.1 million in 2022, then increased by 2.76% to $281.7 million in 2023, then grew by 24.41% to $350.4 million in 2024, then gained by 5.15% to $368.5 million in 2025, then increased by 2.78% to $378.7 million in 2026.
- The last three Non-Current Assets figures came in at $378.7 million (Q1 2026), $368.5 million (Q4 2025), and $362.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Warby Parker | 3.41 Bn | 3.12 Bn | 136.46 Mn | 401.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 401.48 Mn |
| Mar 31, 2026 | 378.72 Mn |
| Dec 31, 2025 | 368.48 Mn |
| Sep 30, 2025 | 362.86 Mn |
| Jun 30, 2025 | 355.80 Mn |
| Mar 31, 2025 | 352.16 Mn |
| Dec 31, 2024 | 350.44 Mn |
| Sep 30, 2024 | 316.78 Mn |
| Jun 30, 2024 | 309.57 Mn |
| Mar 31, 2024 | 296.78 Mn |
| Dec 31, 2023 | 281.69 Mn |
| Sep 30, 2023 | 279.40 Mn |
| Jun 30, 2023 | 273.67 Mn |
| Mar 31, 2023 | 273.32 Mn |
| Dec 31, 2022 | 274.14 Mn |
| Sep 30, 2022 | 267.94 Mn |
| Jun 30, 2022 | 247.75 Mn |
| Mar 31, 2022 | 232.51 Mn |
| Dec 31, 2021 | 112.67 Mn |
| Sep 30, 2021 | 106.07 Mn |